Physiology and pathophysiology of proteinase-activated receptors (PARs): PAR-2-mediated proliferation of colon cancer cell.

Proteinase-activated receptor-2 (PAR-2) has been demonstrated to be highly expressed in the gastrointestinal tract. In the present minireview, we summarize the effects of PAR-1 and PAR-2 stimulation using their activating peptides and agonist proteinases on the calcium signaling and the cell proliferation in DLD-1 cell, a human colon cancer cell line. PAR-2 but not PAR-1 stimulation induced the enhancement of cell proliferation, whereas both PAR-1 and PAR-2 stimulation induced the transient increase in [Ca(2+)](i). PAR-2 stimulation induced the phosphorylation of MEK1/2 and ERK1/2, but PAR-1 stimulation did not. The inhibition of MEK1/2 by PD98059 completely abolished the proliferative response to PAR-2 stimulation. Thus, MEK-ERK activation plays major role in the PAR-2-mediated proliferative response. The coupling of PARs to calcium signaling and MEK-ERK activation may be independent, and varied dependent on cell types.

[1]  K. Chung,et al.  Factor Xa induces mitogenesis of coronary artery smooth muscle cell via activation of PAR‐2 , 2002, FEBS letters.

[2]  T. Masuko,et al.  In vivo evidence that protease‐activated receptors 1 and 2 modulate gastrointestinal transit in the mouse , 2001, British journal of pharmacology.

[3]  C. Rogalski,et al.  Trypsin induces epidermal proliferation and inflammation in murine skin , 2004, Experimental dermatology.

[4]  N. Bunnett,et al.  Protease-activated receptors: contribution to physiology and disease. , 2004, Physiological reviews.

[5]  M. Laburthe,et al.  Protease-activated Receptor 2 in Colon Cancer , 2004, Journal of Biological Chemistry.

[6]  J. Herbert,et al.  Induction of vascular smooth muscle cell growth by selective activation of the proteinase activated receptor-2 (PAR-2). , 1997, Biochemical and biophysical research communications.

[7]  C. Derian,et al.  Differential regulation of human keratinocyte growth and differentiation by a novel family of protease-activated receptors. , 1997, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[8]  M. Hollenberg,et al.  International Union of Pharmacology. XXVIII. Proteinase-Activated Receptors , 2002, Pharmacological Reviews.

[9]  M. Nishibori,et al.  MAP kinase-mediated proliferation of DLD-1 carcinoma by the stimulation of protease-activated receptor 2. , 2003, Life sciences.

[10]  J. Wallace,et al.  Protease-activated receptors in inflammation, neuronal signaling and pain. , 2001, Trends in pharmacological sciences.

[11]  S. Coughlin,et al.  Molecular cloning, expression and potential functions of the human proteinase-activated receptor-2. , 1996, The Biochemical journal.

[12]  M. Hollenberg,et al.  Luminal trypsin may regulate enterocytes through proteinase-activated receptor 2. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[13]  H. Kitagawa,et al.  Protease-activated receptor-2 expression and the role of trypsin in cell proliferation in human pancreatic cancers. , 2003, International journal of oncology.

[14]  M. Hollenberg,et al.  Protease‐activated receptor‐2 (PAR‐2) in the rat gastric mucosa: immunolocalization and facilitation of pepsin/pepsinogen secretion , 2002, British journal of pharmacology.

[15]  P. Poronnik,et al.  Functional effects of protease-activated receptor-2 stimulation on human airway smooth muscle. , 2001, American journal of physiology. Lung cellular and molecular physiology.

[16]  S. Bottomley,et al.  Protease-activated receptor-2 mediates proliferative responses in skeletal myoblasts. , 2000, Journal of cell science.

[17]  M. Laburthe,et al.  Initiation of human colon cancer cell proliferation by trypsin acting at protease-activated receptor-2 , 2001, British Journal of Cancer.

[18]  C. Wahlestedt,et al.  Molecular cloning of a potential proteinase activated receptor. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[19]  V. Wheaton,et al.  Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation , 1991, Cell.

[20]  V. Yatsula,et al.  The proteinase activated receptor-2 (PAR-2) mediates mitogenic responses in human vascular endothelial cells. , 1996, The Journal of clinical investigation.

[21]  M. Nishida,et al.  The protease-activated receptor-2 agonist induces gastric mucus secretion and mucosal cytoprotection. , 2001, The Journal of clinical investigation.

[22]  M. Ghazizadeh,et al.  Protease‐activated receptor (PAR)‐1 and PAR‐2 participate in the cell growth of alveolar capillary endothelium in primary lung adenocarcinomas , 2003, Cancer.

[23]  Patricia Andrade-Gordon,et al.  Endothelial Cell Thrombin Receptors and PAR-2 , 1997, The Journal of Biological Chemistry.

[24]  A. Kawabata,et al.  Protease-activated receptor (PAR), a novel family of G protein-coupled seven trans-membrane domain receptors: activation mechanisms and physiological roles. , 2000, Japanese journal of pharmacology.

[25]  C. Der,et al.  Differential contribution of the ERK and JNK mitogen-activated protein kinase cascades to Ras transformation of HT1080 fibrosarcoma and DLD-1 colon carcinoma cells , 1999, Oncogene.

[26]  G. D. Hunter,et al.  Proteinase-Activated Receptors , 2001 .

[27]  T. Sawada,et al.  A role for protease-activated receptor-2 in pancreatic cancer cell proliferation. , 2004, International journal of oncology.

[28]  P. O'Connor,et al.  RPR‐115135, a farnesyltransferase inhibitor, increases 5‐FU‐ cytotoxicity in ten human colon cancer cell lines: Role of p53 , 2002, International journal of cancer.

[29]  R. Marthan,et al.  Tryptase and agonists of PAR-2 induce the proliferation of human airway smooth muscle cells. , 2001, Journal of applied physiology.

[30]  M. Runge,et al.  Thrombin Regulates Vascular Smooth Muscle Cell Growth and Heat Shock Proteins via the JAK-STAT Pathway* , 2001, The Journal of Biological Chemistry.

[31]  V. Meineke,et al.  Proliferative action of mast-cell tryptase is mediated by PAR2, COX2, prostaglandins, and PPARγ: Possible relevance to human fibrotic disorders , 2002, Proceedings of the National Academy of Sciences of the United States of America.